Back
OncoCyte Vs. John Wiley & Sons Industry Stock Comparison
Sell
36
OCX
OncoCyte
Last Price:
2.77
Seasonality Move:
-25.1%
Sell
50
WLY
John Wiley & Sons
Last Price:
39.98
Seasonality Move:
1.66%
Sell
36
OncoCyte (OCX)
is a Sell
Is OncoCyte a Buy, Sell or Hold?
- The current OncoCyte [OCX] share price is $2.76. The Score for OCX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- OCX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
John Wiley & Sons (WLY)
is a Sell
Is John Wiley & Sons a Buy, Sell or Hold?
- The current John Wiley & Sons [WLY] share price is $39.98. The Score for WLY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- WLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCX Stock Price Chart
WLY Stock Price Chart
What is John Wiley & Sons's stock price today?
-
The John Wiley & Sons share price today is $39.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
OCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 50.88 | Buy |
| Chaikin Money Flow: | 2150 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.68 - 2.88) | Sell |
| Bollinger Bands (100): | (2.69 - 3.03) | Sell |
WLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 64.17 | Buy |
| Chaikin Money Flow: | 218284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.95 - 38.91) | Buy |
| Bollinger Bands (100): | (34.48 - 38.58) | Buy |
OCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.75 | Buy |
| 20-day SMA: | 2.74 | Buy |
| 50-day SMA: | 2.73 | Buy |
| 200-day SMA: | 3.01 | Sell |
| 8-day EMA: | 2.74 | Buy |
| 20-day EMA: | 2.75 | Buy |
| 50-day EMA: | 2.78 | Sell |
| 200-day EMA: | 3.58 | Sell |
WLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.53 | Buy |
| 20-day SMA: | 37.19 | Buy |
| 50-day SMA: | 37.74 | Buy |
| 200-day SMA: | 34.52 | Buy |
| 8-day EMA: | 38.3 | Buy |
| 20-day EMA: | 37.61 | Buy |
| 50-day EMA: | 37.35 | Buy |
| 200-day EMA: | 36.04 | Buy |
OncoCyte Earnings Growth & OCX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.43 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
John Wiley & Sons Earnings Growth & WLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.51 per share, a decrease next quarter of $0.23 per share, a decrease this year of $1.00 per share, and an increase next year of $1.00 per share.
OncoCyte Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
John Wiley & Sons Technical Analysis
| Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||